3-Bromo-6-chloro-1H-pyrrolo[3,2-b]pyridine

Catalog No. :
ACYUBF894
CAS No. :
1190317-85-1
Molecular Formula :
C7H4BrClN2
Molecular Weight :
231.48

IUPAC Name:3-bromo-6-chloro-1H-pyrrolo[3,2-b]pyridine

3-Bromo-6-chloro-1H-pyrrolo[3,2-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$164.00Login to see priceIn stockInquiry
250mg97%$328.00Login to see priceIn stockInquiry
500mg97%$494.00Login to see priceIn stockInquiry
1g97%$822.00Login to see priceIn stockInquiry
5g97%$2465.00Login to see priceIn stockInquiry
10g97%$4106.00Login to see priceIn stockInquiry
25g97%$8212.00Login to see priceIn stockInquiry
50g97%$12319.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-6-chloro-1H-pyrrolo[3,2-b]pyridine
IUPAC Name3-bromo-6-chloro-1H-pyrrolo[3,2-b]pyridine
MDL No.MFCD12963025
Molecular FormulaC7H4BrClN2
Molecular Weight231.48
SMILESClC1=CN=C2C(Br)=CNC2=C1
InChI KeyPCNBZQBBFVMANE-UHFFFAOYSA-N
Synonym3-broMo-6-chloro-1H-pyrrolo[3,2-b]pyridine;1H-Pyrrolo[3,2-b]pyridine, 3-broMo-6-chloro-;3-BroMo-6-chloro-4-azaindole;3-bromo-6-chloro-1H-pyrrolo[3,2-b]pyridine - [B81575]
CAS No.1190317-85-1
PubChem CID53412579

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYUBF894 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYUBF894 route product structure diagram
    ACYUBF8941190317-85-1 In Stock
Inquiry

2. ACYUBF894 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYUBF894 route product structure diagram
    ACYUBF8941190317-85-1 In Stock
Inquiry

Comments (0)